Skip to content

Released Aug 14, 2024, before the open

10-Q filed Aug 14, 2024, 45 days after period end · 0000868278-24-000010

Q2 2024 · 10-Q
Revenue$1.50M−88.6% vs Q2 2023−36.2% vs Q1 2024
Net Income-$6.15MN/M vs Q2 2023N/M vs Q1 2024
EPS Diluted-$0.33N/M vs Q2 2023N/M vs Q1 2024
Gross Profit-$155,000N/M
Operating Income-$7,228,000N/M
Operating Cash Flowderived-$4,842,000N/M
Free Cash Flowderived-$4,842,000N/M
Margins · derived
Gross margin-10.3%−59.1 pt vs Q2 2023
Operating margin-480.6%−445.3 pt vs Q2 2023
Net margin-409.1%−383.1 pt vs Q2 2023

What the release said

The release

Same quarter

MetricQ2 2024Q2 2023Q2 2022Q2 2021
Revenue$1.50M$13.22M$29.09M$9.14M
Net Income-$6.15M-$3.44M$7.45M-$1.40M
EPS Diluted-$0.33-$0.20$0.40-$0.09

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR